Patient info Open main menu

Methocarbamol 750 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
750 mg
Other strengths and forms:
Contains active substance:
Similar medicines:

Patient leaflet - Methocarbamol 750 mg film-coated tablets

1. What Methocarbamol is and what it is used for

Methocarbamol contains the active ingredient methocarbamol (750mg) which belongs to a group of medicines called muscle relaxants.

Methocarbamol is used for the symptomatic treatment of painful muscle tension, especially in the lower back area (lumbago).

Methocarbamol is used in adults.

2. What you need to know before you take Methocarbamol

Do not take Methocarbamol if you:

  • are allergic to methocarbamol, or have had any problems in the

    past with medicines containing methocarbamol

  • are allergic to any of the other ingredients of this medicine

    (listed in section 6)

  • have ever suffered any brain damage or coma
  • suffer from epilepsy or convulsions
  • suffer from muscle weakness (a disease called myasthenia

    gravis)

Warnings and precautions

Talk to your doctor or pharmacist before taking Methocarbamol. Tell your doctor or pharmacist before taking Methocarbamol if you:

  • are pregnant or thinking of becoming pregnant
  • are breastfeeding
  • have, or have had, any kidney or liver problems
  • are having any medical investigations or tests as

    Methocarbamol could interfere with the results. Tell your doctor that you are taking Methocarbamol before you have the test.

Children and adolescents

This medicinal product is not intended for use in children and adolescents as safety and efficacy in these patient groups have not been established.

Other medicines and Methocarbamol

If you are taking any of the following medicines, you should tell your doctor or pharmacist as Methocarbamol may interact with them:

  • Barbiturates which can be taken for epilepsy or to help you sleep.
  • Appetite suppressants to help you lose weight.
  • Medicines for stomach upsets or sea-sickness (anti-

    cholinergics).

  • Psychotropic drugs for the treatment of anxiety, depression or other mental illnesses.
  • Pyridostigmine bromide, which is used for myasthenia gravis.

    You should not take methocarbamol if you have pathological muscle weakness (myasthenia gravis).

  • If you are due to have anaesthetic for any reason, tell your doctor or dentist that you are taking Methocarbamol.

Methocarbamol with alcohol

Consumption of alcohol during methocarbamol treatment may potentiate the effect of the medicine. Do not drink alcohol while you are taking methocarbamol.

Pregnancy, breast-feeding and fertility

Pregnancy

There is no experience available concerning the use of methocarbamol during pregnancy. The potential risk to humans is not known. You should not take methocarbamol during pregnancy.

Breast-feeding

It is not known whether methocarbamol and/or its metabolites pass into human milk. As a precautionary measure, you should not take methocarbamol if you are breast-feeding.

Fertility

No data are available concerning the influence of methocarbamol on human fertility.

Driving and using machines

Methocarbamol may make you feel sleepy. Do not drive or operate machinery until you are sure you are not affected.

Information on Sodium content

This medicine contains less than 1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially ‘sodium-free’.

3. How to take Methocarbamol

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Adults: Take TWO tablets with a little water, FOUR times a day. Sometimes a lower dose may be sufficient. You should spread the doses as evenly as possible over a 24-hour period.

Elderly: older patients may only need half the usual dose to give the same relief from the pain and muscle spasms.

Children: These tablets should not be given to children

Liver impairment: you may need a longer interval between taking the tablets if you have liver disease. You should always follow your doctor's instructions carefully.

These tablets are for short-term treatment. Take them for as long as your doctor has recommended, or until you no longer need them to ease the pain. Return any unused tablets to your pharmacist. Package leaflet: Information for the patient

Methocarbamol 750 mg film-coated tablets

methocarbamol

Black A/s: 210 x 300 mm

Sign / Date Product Name

06.10.2025 & 9:15 AM

Team Leader

Initiator

Additional Information :

Artist:

Ramesh P

Jaya Durga

Method of administration

Methocarbamol is for oral use.

Swallow the film-coated tablets with plenty of water.

The film-coated tablets should be taken for as long as the symptoms of muscle tightness persist, but no longer than 30 days.

If you take more Methocarbamol than you should Contact your doctor immediately, go or take the person to the Accident and Emergency Department of your local hospital. Always take the bottle of Methocarbamol with you, even if it is empty.

If you forget to take Methocarbamol

Take your normal dose when you remember. Always leave at least 4 hours before taking any more tablets. DO NOT TAKE A DOUBLE DOSE OF TABLETS TO MAKE UP FOR A MISSED DOSE.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you notice any of the following rare symptoms, you should STOP taking your tablets and tell your doctor immediately:

  • confusion, convulsions, fits, and rash or swelling of the face or

    neck and shortness of breath which may be a sign of an allergy

Rare (may affect up to 1 in 1,000 people):

Conjunctivitis, headache, dizziness, metallic taste, decreased blood pressure, nasal congestion, angioedema (acute-onset swelling of parts of the tissue and skin), rash, itching, nettle rash (urticaria), fever

Very rare (may affect up to 1 in 10,000 people):

Anaphylactic reactions (allergic hypersensitivity reactions), loss of appetite, restlessness, anxiety, confusion, fainting, involuntary eye movement, giddiness, trembling, seizures, impaired vision, slow heart beat, hot flushes, retching (nausea) and vomiting

Not known (frequency cannot be estimated from the available data):

Drowsiness, disturbance of coordination

Reporting of side effects

If your child gets any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Methocarbamol

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and bottle after EXP. The first two numbers indicate the month; the last four numbers indicate the year. The expiry date refers to the last date of that month.

This medicine does not require any special storage conditions Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Methocarbamol contains

The active substance is methocarbamol

Each film-coated tablet contains 750 mg methocarbamol The other ingredients are:

Tablet core: maize starch, sodium starch glycolate (Type – A), povidone (K-30), sodium laurilsulfate, talc and magnesium stearate

Tablet coat: hypromellose 2910 (6mPas), titanium dioxide and macrogol 400.

What Methocarbamol looks like and contents of the pack

Methocarbamol 750 mg film-coated tablets are white, film coated, capsule shaped biconvex tablet, debossed with ‘METT’ on one side and ‘750’ on the other side.

Methocarbamol 750 mg film-coated tablets are supplied in a white opaque round HDPE container.

Pack sizes: 100 film-coated tablets.

Marketing Authorisation Holder

Milpharm Limited

1 Roundwood Avenue

Stockley Park, Uxbridge

UB11 1AF

United Kingdom

Manufacturer

APL Swift Services (Malta) Limited

HF26, Hal Far Industrial Estate, Hal Far,

Birzebbugia, BBG 3000, Malta

Or

Milpharm Limited

1 Roundwood Avenue

Stockley Park, Uxbridge

UB11 1AF

United Kingdom

Or

Generis Farmacêutica, S.A.,

Rua João de Deus, n.o 19, Venda Nova, 2700-487 Amadora, Portugal

This leaflet was last revised in 10/2025.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 16363/0683

Last revision stated in the text: October 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Methocarbamol 750 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Methocarbamol
Strength 750 mg
Pharmaceutical form Oral tablet
White, film coated, capsule shaped biconvex tablet, debossed with ‘METT’ on one side and ‘750’ on the other side.
Tablet size: 19 x 8 mm
How is it taken Oral
Excipients Maize starch, Sodium starch glycolate (Type – A), Povidone (K-30), Sodium laurilsulfate, Talc, Magnesium stearate, Hypromellose 2910 (6 mPas), Titanium dioxide, Macrogol 400
Pack sizes 100 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years.
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Muscle relaxants, centrally acting agents; Carbamic acid esters
  1. M Musculo-skeletal system drugs
    1. M03 Muscle relaxants
      1. M03B Muscle relaxants, centrally acting agents
        1. M03BA Carbamic acid esters, centrally acting muscle relaxants
          1. M03BA03 methocarbamol
Marketing authorisation PL 16363/0683 (first authorised 3 August 2026)
Marketing authorisation holder Milpharm Limited
Codes GTIN 8901175063345 · BNF 10020200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.